Cwm, LLC Pharma Cyte Biotech, Inc. Transaction History
Cwm, LLC
- $33.3 Billion
- Q3 2025
A detailed history of Cwm, LLC transactions in Pharma Cyte Biotech, Inc. stock. As of the latest transaction made, Cwm, LLC holds 1 shares of PMCB stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 1
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PMCB
# of Institutions
29Shares Held
682KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA127KShares$112,6760.0% of portfolio
-
Ayrton Capital LLC Westport, CT92.1KShares$81,9577.31% of portfolio
-
Equitec Proprietary Markets, LLC82.7KShares$73,6270.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.9KShares$66,6770.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny49.8KShares$44,3220.0% of portfolio
About PharmaCyte Biotech, Inc.
- Ticker PMCB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,750,100
- Market Cap $18.5M
- Description
- PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...